These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7379444

  • 1. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
    Moskowitz RM, Cohn JN.
    Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
    De Ponti C, Bardi U, Marchetti M.
    Arzneimittelforschung; 1976 Jun; 26(11):2089-92. PubMed ID: 1037254
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
    Groves BM, Rubin LJ, Frosolono MF, Cato AE, Reeves JT.
    Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
    [Abstract] [Full Text] [Related]

  • 4. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM, Irvine NA.
    J Cardiovasc Pharmacol; 1986 Dec; 8(3):527-33. PubMed ID: 2425168
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of oxdralazine and dihydralazine in essential hypertension.
    Salvadeo A, Villa G, Segagni S, Piazza W, Criscuolo D.
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
    [Abstract] [Full Text] [Related]

  • 6. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE, Kardel T, Lund JO, McNair A, Trap-Jensen J.
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [Abstract] [Full Text] [Related]

  • 7. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ, Peter RH.
    N Engl J Med; 1980 Jan 10; 302(2):69-73. PubMed ID: 7350435
    [Abstract] [Full Text] [Related]

  • 8. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE, Keene BW, McGuirk SM, Sato T.
    Am J Vet Res; 1994 Feb 10; 55(2):262-9. PubMed ID: 8172418
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
    Rubin LJ, Peter RH.
    Am J Cardiol; 1981 Jan 10; 47(1):116-22. PubMed ID: 7457397
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M, Gilbert CA, Rutledge CO, McNay JL.
    Clin Pharmacol Ther; 1975 Aug 10; 18(2):145-53. PubMed ID: 1097150
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F.
    Am Rev Respir Dis; 1987 Feb 10; 135(2):288-93. PubMed ID: 3813189
    [Abstract] [Full Text] [Related]

  • 12. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
    Baldoli E, Sardi A, Dezulian V, Capellini M, Bianchi G.
    Arzneimittelforschung; 1973 Nov 10; 23(11):1591-5. PubMed ID: 4801666
    [No Abstract] [Full Text] [Related]

  • 13. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF, Baldoli E, Marchetti G, Glässer A.
    Arzneimittelforschung; 1986 Nov 10; 36(1):84-8. PubMed ID: 3954821
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB, Gonik B, Dorman KF.
    Surg Gynecol Obstet; 1985 Sep 10; 161(3):240-4. PubMed ID: 4035539
    [Abstract] [Full Text] [Related]

  • 15. Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
    Lopez LM, Mehta JL, Baz R, Aguila E.
    Clin Pharmacol Ther; 1984 Oct 10; 36(4):444-50. PubMed ID: 6478732
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic activity of L 6150. Systemic and coronary circulation.
    Sardi A, Caravaggi AM, Baldoli E.
    Naunyn Schmiedebergs Arch Pharmacol; 1973 Oct 10; 279(3):301-12. PubMed ID: 4270747
    [No Abstract] [Full Text] [Related]

  • 17. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
    Kittleson MD, Johnson LE, Oliver NB.
    J Am Vet Med Assoc; 1985 Aug 01; 187(3):258-61. PubMed ID: 4030462
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J, Skret A, Piela A, Szmigiel Z, Zaczek T.
    Obstet Gynecol; 1985 Oct 01; 66(4):453-8. PubMed ID: 4047535
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of hydralazine HCl administration in horses.
    Bertone JJ.
    Am J Vet Res; 1988 May 01; 49(5):618-21. PubMed ID: 3395006
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J, Borer JS, Moses JW, Goldberg HL, Niarchos AP, Whitman HH, Mermelstein M.
    Am J Cardiol; 1984 Sep 01; 54(6):646-50. PubMed ID: 6475787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.